'Unsubstantiated’ fears about sweeteners adding to diabesity epidemic

Confusion and misunderstanding still surrounds artificial sweeteners and it is harming the fight against obesity and diabetes, according to research led by Liverpool Hope University, UK. The investigators are calling for an education campaign to improve the reputation of non-nutritive sweeteners in order to get more people making the sugar-sweetener swap. 

Chinese people maybe more susceptible to obesity-related health risks

Chinese people are more likely to face high blood pressure and other health risks as a result of higher body mass index (BMI) and waist circumference than people from other racial and ethnic groups, according to a researchers from the Shanghai Jiaotong University School of Medicine in Shanghai, China. The findings were reported in the paper, ‘Chinese Adults Are More Susceptible to Effects of Overall Obesity and Fat Distribution on Cardiometabolic Risk Factors’, published in Journal of Clinical Endocrinology & Metabolism

Obesity and excess body fat associated mortality exceeds smoking mortality

Obesity and excess body fat may have contributed to more deaths in England and Scotland than smoking since 2014, according to research led by the University of Glasgow. Between 2003 and 2017 the percentage of deaths attributable to smoking are calculated to have decreased from 23.1% to 19.4% while deaths attributable to obesity and excess body fat are calculated to have increased from 17.9% to 23.1%.

STEP outcomes: Semaglutide could be ‘gamechanger’ in battle against obesity

One third (35%) of patients who received semaglutide for treating obesity lost more than one-fifth (greater than or equal to 20%) of their total body weight, according to the outcomes from the ‘Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity’ (STEP 1) randomised clinical trial. The findings reported in the paper, ‘Once-Weekly Semaglutide in Adults with Overweight or Obesity’, from the large-scale international trial were published in the New England Journal for Medicine.